# MegaRobo

> MegaRobo is a VC fund in Beijing backing Biotechnology and Health Care. See 3 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Beijing, China
- Total investments: 3
- Last investment: Oct 2023
- Lead investor: 0%
- Last updated: Aug 2026
- Website: http://www.megarobo.tech/

MegaRobo is a VC fund in Beijing focused on Biotechnology and Health Care. AI & Robotics Company based in Beijing,China.

## Contacts

5 contacts available for MegaRobo. Shizune tracks 2 team members at MegaRobo. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/megarobo?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 2 | 67% |
| Health Care | 1 | 33% |
| Therapeutics | 1 | 33% |
| Health Diagnostics | 1 | 33% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 1 | 33% |
| Series A | 1 | 33% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 1 | 33% |
| United Kingdom | 1 | 33% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Daniel Huang | Founder | 0 | https://shizune.co/investors/profile/daniel-huang-a28f |
| Zhixin Qiao | Co-founder & CMO | 0 | https://shizune.co/investors/profile/zhixin-qiao |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| ENSEM Therapeutics | ENSEM Therapeutics is a pioneering drug discovery and development company that leverages its unique Kinetic EnsembleTM platform to develop innovative small-molecule precision medicines for oncology, with potential expansion into genetic disorders and other disease areas. | $10M | Series A | Oct 23, 2023 |  |
| OxCan | OxCan is a startup that uses machine learning and liquid biopsy for early lung cancer detection. | $3.6M | Seed | Jan 10, 2023 |  |
| OxCan | OxCan is a startup that uses machine learning and liquid biopsy for early lung cancer detection. | $1.8M | Seed | Sep 06, 2021 |  |

3 of 3 investments shown.

## Co-investors
- [Oxford Technology Management](https://shizune.co/investors/profile/oxford-technology-management) — VC Fund, 2 deals together
- [Boquan Capital](https://shizune.co/investors/profile/boquan-capital) — VC Fund, 1 deal together
- [Cancer Research UK](https://shizune.co/investors/profile/cancer-research-uk) — VC Fund, 1 deal together
- [Civilization Ventures](https://shizune.co/investors/profile/civilization-ventures) — VC Fund, 1 deal together
- [Eka Ventures](https://shizune.co/investors/profile/eka-ventures) — VC Fund, 1 deal together
- [Legend Star](https://shizune.co/investors/profile/legendstar) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does MegaRobo invest in?

MegaRobo invests primarily in Biotechnology, Health Care and Therapeutics startups, most often at Seed and Series A stage. Most of the 3 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact MegaRobo?

Public channels for MegaRobo include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at MegaRobo?

The team at MegaRobo includes Daniel Huang (Founder) and Zhixin Qiao (Co-founder & CMO). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co